6-OHDA lesion in medial forebrain bundle

By Santiago Unda, MD, Mihaela Stavarache, Michael Kaplitt, MD, PhD and Roberta Marongiu, PhD
View Published Protocol

Output Details

Description
Lesion of the medial forebrain bundle using 6-OHDA to induce parkinsonian-like deficits in mice.
Identifier (DOI)
10.17504/protocols.io.8epv5r9o4g1b/v1
Tags
  • 6-OHDA
  • Animal
  • In Vivo
  • Medial forebrain bundle
  • Motor symptoms
  • Mouse
Team
Team Kaplitt
Program
Collaborative Research Network
Theme
Circuitry and Brain-Body Interactions

Meet the Authors

Related Research

Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficits

Study shows increasing PGK1 gene expression enhances neuronal ATP production, protecting against synaptic dysfunction in Parkinson's disease. Boosting bioenergetics with PGK1 may be a promising therapeutic approach for PD.

View Article

Videos from Alcacer et al., Cell Reports 2025

Video files from manuscript Abnormal hyperactivity of striatal ensembles encodes distinct dyskinetic behaviors revealed by high-resolution clustering, Alcacer et al., Cell Reports 2025.

View Dataset

6-OHDA mouse model of Parkinson’s disease

Protocol for creating a Parkinson's disease mouse model using 6-OHDA involves injecting different doses into the brain to induce varying levels of dopaminergic damage.

View Protocol
View More Outputs
Aligning Science Across Parkinson's
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.